140MO HER2DX Genomic Test in HER2-positive/hormone Receptor-Positive (HER2+/HR+) Breast Cancer (BC) Treated with Neoadjuvant Trastuzumab (T) and Pertuzumab (P): A Correlative Analysis from the PerELISA Trial

V. Guarneri,M. V. Dieci,G. Griguolo,L. Pare Brunet,M. Marin,F. Miglietta,M. Bottosso,C. A. Giorgi,P. Blasco,O. Castillo,P. Galvan,P. Jares,J. A. Puig-Butille,A. Vivancos,P. Villagrasa Gonzalez, J. Parker,C. M. Perou,P. F. Conte,A. Prat

Annals of oncology（2022）

Cited 0|Views34
No score
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined